Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZoMARS: Zoledronic Acid for Bone Marrow Edema Syndrome
NCT01348269Phase 3Completed
- Start
- May 2011
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in bone marrow edema syndrome (BMES). Started May 2011; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone marrow edema syndrome (BMES)
Beyond the preview
Go deeper on NCT01348269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348269.